March 2022 SEC Updates
1. On March 31, 2022, the SEC obtained a final judgement against Gregory Lemelson, Lemelson Capital Management, LLC, and The Amvona Fund. Gregory Lemelson and Lemelson Capital Management, LLC were charged with making false statements to drive down the price of Ligand Pharmaceuticals Inc. and profit from a short position in Ligand’s stock. Lemelson and … Read More